• Something wrong with this record ?

In Search of the Perfect Thrombosis and Bleeding-Associated Cancer Scale

MZ. Wojtukiewicz, P. Tesarova, D. Karetová, J. Windyga

. 2024 ; 50 (3) : 443-454. [pub] 20231018

Language English Country United States

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc24006627

Thrombosis and bleeding are commonly observed in cancer patients, and their management is crucial for positive patient outcomes. A comprehensive, prophylactic, and therapeutic management of venous thrombosis should focus on identifying the patients who would benefit most from treatment to reduce mortality and minimize the risk of thrombosis recurrence without significantly increasing the risk of bleeding. Existing cancer scales provide valuable information for assessing the overall burden of cancer and guiding treatment decisions, but their ability to predict thrombotic and bleeding events remains limited. With increasing knowledge of the pathophysiology of cancer and the availability of advanced anticancer therapies, new risk factors for cancer-associated thrombosis and bleeding are being identified. In this report, we analyze the current literature and identify new risk factors for venous thrombosis and bleeding which are not included in routinely used risk scores. While some existing cancer scales partially capture the risk of thrombosis and bleeding, there is a need for more specific and accurate scales tailored to these complications. The development of such scales could improve risk stratification, aid in treatment selection, and enhance patient care. Therefore, further research and development of novel cancer scales focused on thrombosis and bleeding are warranted to optimize patient management and outcomes.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24006627
003      
CZ-PrNML
005      
20240423155417.0
007      
ta
008      
240412s2024 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1055/s-0043-1776003 $2 doi
035    __
$a (PubMed)37852295
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Wojtukiewicz, Marek Z $u Department of Oncology, Medical University of Bialystok, Bialystok, Poland $u Comprehensive Cancer Center, Bialystok, Poland
245    10
$a In Search of the Perfect Thrombosis and Bleeding-Associated Cancer Scale / $c MZ. Wojtukiewicz, P. Tesarova, D. Karetová, J. Windyga
520    9_
$a Thrombosis and bleeding are commonly observed in cancer patients, and their management is crucial for positive patient outcomes. A comprehensive, prophylactic, and therapeutic management of venous thrombosis should focus on identifying the patients who would benefit most from treatment to reduce mortality and minimize the risk of thrombosis recurrence without significantly increasing the risk of bleeding. Existing cancer scales provide valuable information for assessing the overall burden of cancer and guiding treatment decisions, but their ability to predict thrombotic and bleeding events remains limited. With increasing knowledge of the pathophysiology of cancer and the availability of advanced anticancer therapies, new risk factors for cancer-associated thrombosis and bleeding are being identified. In this report, we analyze the current literature and identify new risk factors for venous thrombosis and bleeding which are not included in routinely used risk scores. While some existing cancer scales partially capture the risk of thrombosis and bleeding, there is a need for more specific and accurate scales tailored to these complications. The development of such scales could improve risk stratification, aid in treatment selection, and enhance patient care. Therefore, further research and development of novel cancer scales focused on thrombosis and bleeding are warranted to optimize patient management and outcomes.
650    _2
$a lidé $7 D006801
650    _2
$a antikoagulancia $x terapeutické užití $7 D000925
650    12
$a trombóza $x farmakoterapie $7 D013927
650    12
$a žilní trombóza $x etiologie $7 D020246
650    _2
$a krvácení $x chemicky indukované $7 D006470
650    12
$a nádory $x farmakoterapie $7 D009369
655    _2
$a časopisecké články $7 D016428
700    1_
$a Tesarova, Petra $u Department of Oncology, Institute of Radiation Oncology, First Faculty of Medicine, Charles University and Bulovka University Hospital, Prague, Czech Republic
700    1_
$a Karetová, Debora $u Second Department of Medicine-Department of Cardiovascular Medicine, Charles University and General University Hospital, Prague, Czech Republic
700    1_
$a Windyga, Jerzy $u Department of Hemostasis Disorders and Internal Medicine, Laboratory of Hemostasis and Metabolic Diseases, Institute of Hematology and Transfusion Medicine in Warsaw, Warsaw, Poland
773    0_
$w MED00010623 $t Seminars in thrombosis and hemostasis $x 1098-9064 $g Roč. 50, č. 3 (2024), s. 443-454
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37852295 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240412 $b ABA008
991    __
$a 20240423155413 $b ABA008
999    __
$a ok $b bmc $g 2080938 $s 1216394
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 50 $c 3 $d 443-454 $e 20231018 $i 1098-9064 $m Seminars in thrombosis and hemostasis $n Semin Thromb Hemost $x MED00010623
LZP    __
$a Pubmed-20240412

Find record

Citation metrics

Archiving options